Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Maternal and Perinatal Outcomes of VTE

Maternal and perinatal outcomes of venous thromboembolism in high-risk cohort using a multidisciplinary treatment approach

Adapted from Ernst DM et al. Int J Gynecol Obstet. 2021;154(3): 500–507.

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Maternal and perinatal outcomes of venous thromboembolism in high-risk cohort using a multidisciplinary treatment approach

Adapted from Ernst DM et al. Int J Gynecol Obstet. 2021;154(3): 500–507.

Maternal and Perinatal Outcomes of VTE

Atopic Dermatitis story